Fabry disease
MONDO:0010526Fabry disease (FD) is a progressive, inherited, multisystemic lysosomal storage disease characterized by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations.
Also known as: Alpha-galactosidase A deficiency, Anderson-Fabry disease, FD, Fabry disease, Fabry's disease, Fd, angiokeratoma corporis diffusum, diffuse angiokeratoma
61 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can a single gene infusion rewrite the story of fabry disease?
⭐️ CURE ⭐️ TerminatedThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase: PHASE1, PHASE2 • Sponsor: Spur Therapeutics • Aim: ⭐️ CURE ⭐️
Last updated Aug 08, 2026 00:03 UTC
-
Fabry disease sperm study halted early
Knowledge-focused TerminatedThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC